Skip Navigation

Cardiovascular Research 2002 55(4):708-709; doi:10.1016/S0008-6363(02)00507-2
© 2002 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Link, A.
Right arrow Articles by Böhm, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Link, A.
Right arrow Articles by Böhm, M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2002, European Society of Cardiology

Potential role of dendritic cells in atherogenesis

Andreas Link* and Michael Böhm

Innere Medizin III; Universitätskliniken des Saarlandes, Kirrberger Straße, D-66424 Homburg/Saar, Germany

andreas.link@telemed.de

* Corresponding author. Tel.: +49-6841-1623-372; fax: +49-6841-1623-369

Received 10 June 2002; accepted 11 June 2002

The first 10% of the full text of this article appears below.

See article by Alderman et al. [13] (pages 806–819) in this issue.

Dendritic cells (DCs), originally described by Steinmann and Cohn in 1973, play a crucial role in initiation of an immune response: they are the key antigen presenting cells (APCs) [1]. They originate from hematopoietic stem cells in bone marrow, migrate as immature precursors within the monocyte cell population in the blood stream, and emigrate into different tissues. Within these tissues, . . . [Full Text of this Article]


   1. Dendritic cells and atherogenesis
 

   2. Perspectives
 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Cardiovasc ResHome page
E. Ibeas, L. Fuentes, R. Martin, M. Hernandez, and M. L. Nieto
Secreted phospholipase A2 type IIA as a mediator connecting innate and adaptive immunity: new role in atherosclerosis
Cardiovasc Res, January 1, 2009; 81(1): 54 - 63.
[Abstract] [Full Text] [PDF]

Home page
 Postgrad. Med. J.Home page
S Ranjit and L Dazhu
Potential role of dendritic cells for progression of atherosclerotic lesions.
Postgrad. Med. J., September 1, 2006; 82(971): 573 - 575.
[Abstract] [Full Text] [PDF]

Home page
 Asian Cardiovasc. Thorac. Ann.Home page
R. Sharma and D.-Z. Li
Role of Dendritic Cells in Atherosclerosis
Asian Cardiovasc Thorac Ann, April 1, 2006; 14(2): 166 - 169.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
J. Ge, Q. Jia, C. Liang, Y. Luo, D. Huang, A. Sun, K. Wang, Y. Zou, and H. Chen
Advanced Glycosylation End Products Might Promote Atherosclerosis Through Inducing the Immune Maturation of Dendritic Cells
Arterioscler Thromb Vasc Biol, October 1, 2005; 25(10): 2157 - 2163.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
W. Cao, Y. V Bobryshev, R. S.A Lord, R. E.I Oakley, S. H Lee, and J. Lu
Dendritic cells in the arterial wall express C1q: potential significance in atherogenesis
Cardiovasc Res, October 15, 2003; 60(1): 175 - 186.
[Abstract] [Full Text] [PDF]